China Predictive Biomarkers Market Size & Outlook, 2025-2030
Related Markets
China predictive biomarkers market highlights
- The China predictive biomarkers market generated a revenue of USD 946.8 million in 2024 and is expected to reach USD 2,847.8 million by 2030.
- The China market is expected to grow at a CAGR of 20.8% from 2025 to 2030.
- In terms of segment, cancer was the largest revenue generating indication in 2024.
- Immunological Diseases is the most lucrative indication segment registering the fastest growth during the forecast period.
Predictive biomarkers market data book summary
| Market revenue in 2024 | USD 946.8 million |
| Market revenue in 2030 | USD 2,847.8 million |
| Growth rate | 20.8% (CAGR from 2025 to 2030) |
| Largest segment | Cancer |
| Fastest growing segment | Immunological Diseases |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, Other |
Other key industry trends
- In terms of revenue, China accounted for 3.9% of the global predictive biomarkers market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan predictive biomarkers market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,924.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Predictive Biomarkers Market Scope
Predictive Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| PacBio | View profile | 501-1000 | Menlo Park, California, United States, North America | https://www.pacb.com |
| Genomic Health | View profile | 501-1000 | Redwood City, California, United States, North America | http://www.genomichealth.com |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.perkinelmer.com |
| Bio-Techne Corp | View profile | 3050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | https://www.bio-techne.com |
| Myriad Genetics Inc | View profile | 2700 | 320 Wakara Way, Salt Lake City, UT, United States, 84108 | https://www.myriad.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
China predictive biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to predictive biomarkers market will help companies and investors design strategic landscapes.
Cancer was the largest segment with a revenue share of 43.27% in 2024. Horizon Databook has segmented the China predictive biomarkers market based on cancer, cardiovascular diseases, neurological diseases, immunological diseases, other covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to China predictive biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China predictive biomarkers market databook
-
Our clientele includes a mix of predictive biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China predictive biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into China predictive biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China predictive biomarkers market size, by indication, 2018-2030 (US$M)
China Predictive Biomarkers Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
